Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 81 | 76 | 43 | 209 | 290 |
| Gross Profit | 81 | 76 | 43 | 209 | 290 |
| Operating Expenses | 29,339 | 28,357 | 39,875 | 28,070 | 24,329 |
| Operating Income | -29,258 | -28,281 | -39,832 | -27,861 | -24,039 |
| Interest Expense | 71 | 105 | 64 | 65 | 119 |
| Other Income | 2,346 | 2,197 | 1,613 | 1,957 | 2,159 |
| Pre-tax Income | -26,983 | -26,189 | -38,283 | -25,969 | -21,999 |
| Net Income Continuous | -26,983 | -26,189 | -38,283 | -25,969 | -21,999 |
| Net Income Discontinuous | 197 | N/A | N/A | N/A | 514 |
| Net Income | $-26,786 | $-26,189 | $-37,490 | $-25,969 | $-21,485 |
| EPS Basic Total Ops | -0.22 | -0.25 | -0.51 | -0.35 | -0.29 |
| EPS Basic Continuous Ops | -0.22 | -0.25 | -0.51 | -0.35 | -0.30 |
| EPS Basic Discontinuous Ops | 0.00 | N/A | N/A | N/A | 0.01 |
| EPS Diluted Total Ops | -0.22 | -0.25 | -0.51 | -0.35 | -0.29 |
| EPS Diluted Continuous Ops | -0.22 | -0.25 | -0.51 | -0.35 | -0.30 |
| EPS Diluted Discontinuous Ops | 0.00 | N/A | N/A | N/A | 0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.25 | N/A | -0.35 | -0.30 |
| EBITDA(a) | $-28,778 | $-27,645 | $-39,221 | $-27,644 | $-24,081 |